Magenta Therapeutics Stock

Invest in stocks with eToro from 50 EUR

Detail	Data
Volume (24h):	214,632 shares
P/E Ratio:	/
Forward P/E:	-5.40
EPS:	-2.83 USD
Forward EPS:	-3.26 USD
Number of Shares:	32,160,000 shares
Market Capitalization:	565,694,400.00 USD

The interactive chart displays the price movement of Magenta Therapeutics shares and updates every 15 minutes. It shows both the current price and historical trends. The chart offers various time frames, including daily, weekly, or monthly views, as well as the entire trading history.

Disclaimer: The data provided is for informational purposes only. Despite our efforts to ensure accuracy, it may contain errors or be outdated. We strongly recommend verifying the data from other independent sources. No investment decisions should be made based on this information.

Dividend

Dividend	Value
Dividend Amount	According to our data, the company Magenta Therapeutics does not currently pay dividends.
Annual Yield %:	-
Ex-dividend Date:	-
5-Year Avg Yield %:	-
Payout Ratio:	-
Last Dividend Value:	-
Last Dividend Date:	-

Analyst Forecast

Most analysts have issued a none recommendation for Magenta Therapeutics stock. The current number of analysts covering this company is 10. The highest target price is 84 USD, while the lowest target price is 34 USD. The median target valuation set by analysts is 50.5 USD. These forecasts and recommendations provide insight into how analysts view the future stock performance of Magenta Therapeutics.

Analysts	Recommendation
Issued Recommendation:	According to our data, the recommendation for Magenta Therapeutics stock is: none
Number of Analysts:	10
Highest Target Price:	84 USD
Lowest Target Price:	34 USD
Median Target Price:	50.5 USD

Fundamental Indicators

Indicator	Data
Total Revenue:	6,524,000.00 USD
Net Income:	-100,732,000.00 USD
Price-to-Book (P/B):	1.72
PEG Ratio:	/
Exchange:	NasdaqCM
Industry:	Biotechnology
Sector:	Healthcare
Number of Employees:	78
Country:	United States

Where to Buy Magenta Therapeutics Stock?

You can purchase Magenta Therapeutics stock on the NasdaqCM under the ticker symbol: DNTH. Several stock brokers or banks offer trading services for these stocks. Popular stock brokers like XTB and eToro allow you to buy real stocks and ETFs with zero or minimal commissions. Banks usually charge higher fees. Remember, investing in stocks involves risks, so it's important to carefully consider your financial situation and investment goals.

*To verify the availability of specific stocks on the platform, it's a good idea to first open a free demo account. Not all stocks are available.

Real stocks and ETFs. Low minimum deposit, only 50 EUR. Option to copy trades. Advanced stock analysis and free education.

Trustpilot rating 4.4/5 Google play rating 4.2/5

Invest in Stocks with eToro

★★★★★ 5.0

Real stocks and ETFs + free demo account. Low fees + fast customer support. More than 5,200 instruments available for trading. Free training and education. Regular live streams on YouTube.

Trustpilot rating 3.6/5 Google play rating 4.5/5

Try Free Demo Account

★★★★☆ 4.8

Risk warning: Trading CFDs involves a high risk of financial loss. Between 51%-eToro -89% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

More Information on Magenta Therapeutics Stock

Indicator	Value
Company Revenue:	6,524,000.00 USD
EBITDA:	-117,096,000.00 USD - Negative EBITDA may signal financial challenges or growth investments.
Earnings Per Share:	-2.83 USD
Book Value Per Share:	10.23 USD
Total Cash:	263,230,000.00 USD
Total Cash per Share:	8.19 USD
Total Debt:	1,396,000.00 USD
Debt to Equity Ratio:	0.00
Quick Ratio	15.59
Current Ratio	15.99
Free Cash Flow	-52,444,124.00 USD
Operating Cash Flow	-90,869,000.00 USD
Gross Margins	100.00 %
EBITDA Margins	-
Operating Margins	-2,852.71 %
Profit Margins	-
Return on Assets	-20.0 %
Return on Equity	-28.7 %
Earnings Growth (1 year)	-
Revenue Growth (1 year)	33.1 %
Quarterly Earnings Year-over-Year Growth	-
Market Capitalization	565,694,400.00 USD
Enterprise Value	301,930,496.00 USD
EV/Revenue	46.28
EV/EBITDA	-2.578
Float Shares	10,988,423 shares
Shares Outstanding	32,160,000 shares
Held Percent Insiders	0.08 %
Held Percent Institutions	119.96 %
Shares Short	6,370,624
Shares Short Prior Month	5,901,485
Date Short Interest	2025-05-15
Short Percentage of Total Shares	19.81 %
Short Ratio	24.72
Beta	-
Short Percentage of Float	24.24 %
Implied Shares Outstanding	32,160,000

Frequently Asked Questions (FAQ)

1️⃣ Does Magenta Therapeutics pay dividends?

According to our data, the company Magenta Therapeutics does not pay dividends yet, even in 2025.

2️⃣ Where to buy Magenta Therapeutics shares?

Magenta Therapeutics shares are traded on the NasdaqCM stock exchange under the ticker: DNTH. You can buy or trade them through a variety of stock brokers who provide real stock trading services.

3️⃣ What is the forecast for Magenta Therapeutics shares?

According to our data, the recommendation for Magenta Therapeutics shares is from a total of 10 analysts. The average target price prediction is 50.5 USD per share.

4️⃣ What is the total number of shares and the value of Magenta Therapeutics on the stock exchange?

The total number of Magenta Therapeutics shares on the exchange is 32,160,000.00 shares, which at the current market capitalization gives the company a total valuation of 565,694,400.00 USD.